Medications starting with

The drug is intended for the treatment of erectile dysfunction in adult men. Sexual stimulation is required for it to work.

Dosage form: tablets

ATC code: G04BE10

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is used to treat various types of cancer, including metastatic colorectal cancer, breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial cancer of the ovaries and fallopian tubes, primary peritoneal cancer, cervical cancer, and recurrent glioblastoma.

Dosage form: concentrate for infusion solution

ATC code: L01FG01

Manufacturer: Roche Diagnostics GmbH (manufacturing of unpackaged product, primary packaging, secondary packaging, quality control testing and batch release)

The drug is used to treat bacterial infections in adults (from 18 years of age), specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.

Dosage form: tablets, film-coated

ATC code: J01MA14

Manufacturer: Bayer AG (entire production cycle (production of unpackaged products, primary packaging, secondary packaging, quality control, batch release))

The drug is used to treat community-acquired pneumonia, as well as complicated infections of the skin and subcutaneous tissues. It should be used only when other antibacterial agents recommended for initial treatment are inappropriate.

Dosage form: solution for infusion

ATC code: J01MA14

Manufacturer: Bayer AG (batch release)

The drug is used for the symptomatic treatment of venolymphatic insufficiency (heaviness in the legs, pain, edema, nocturnal cramps, varicose ulcers) and for the treatment of hemorrhoids.

Dosage form: tablets, film-coated

ATC code: C05CA53

Manufacturer: Farmak JSC

The drug is used for the treatment of Meniere's disease and syndrome (which is accompanied by dizziness, nausea, hearing loss, and tinnitus), as well as for the symptomatic treatment of vestibular dizziness of various origins.

Dosage form: tablets

ATC code: N07CA01

Manufacturer: Pharmaceutical Plant "POLPHARMA" S.A. (Full production cycle: manufacturing, primary packaging, secondary packaging, quality control and batch release)

The drug is used for the treatment of Meniere's disease and syndrome (which is accompanied by dizziness, nausea, hearing loss, and tinnitus), as well as for the symptomatic treatment of vestibular dizziness of various origins.

Dosage form: tablets

ATC code: N07CA01

Manufacturer: Pharmaceutical Plant "POLPHARMA" S.A. (Full production cycle: manufacturing, primary packaging, secondary packaging, quality control and batch release)

The drug is used for the treatment of Meniere's disease and syndrome (which is accompanied by dizziness, tinnitus, and hearing loss), as well as for the symptomatic treatment of vestibular dizziness of various origins.

Dosage form: tablets

ATC code: N07CA01

Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (Full production cycle: manufacturing, primary packaging, secondary packaging, quality control and batch release)

The drug is used for the treatment of Meniere's disease and syndrome (which is accompanied by dizziness, nausea, vomiting, hearing loss, and tinnitus), as well as for the symptomatic treatment of vestibular vertigo.

Dosage form: solution, oral

ATC code: N07CA01

Manufacturer: Joint Ukrainian-Spanish Enterprise "Sperko Ukraine"

The drug is used for the prevention and treatment of calcium and/or vitamin D3 deficiency in adults, as well as an adjunct to the treatment of osteoporosis.

Dosage form: tablets, film-coated

ATC code: A12AX

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is used to treat non-hospital pneumonia, as well as complicated infections of the skin and subcutaneous tissues.

Dosage form: solution for infusion

ATC code: J01MA14

Manufacturer: Vioser S.A. Parenteral Solutions Industries (unpacked product, primary packaging, secondary packaging, control)

The drug is used to treat new or re-emerging pandemic infections caused by the influenza virus if other antiviral agents have failed or were ineffective.

Dosage form: tablets

ATC code: J05AX27

Manufacturer: TOYAMA FACTOR FUJIFILM Toyama Chemical Co., Ltd

The drug is prescribed for the treatment of symptoms of moderate to severe benign prostatic hyperplasia. It also helps to reduce the risk of acute urinary retention and the need for surgical intervention.

Dosage form: capsules, soft gelatin

ATC code: G04CB02

Manufacturer: Delpharm Poznan S.A.

The drug is used for emergency contraception in cases where no protection methods were used during sexual intercourse or the method used was unreliable. It should be taken within the first 72 hours after unprotected contact.

Dosage form: tablets

ATC code: G03AD01

Manufacturer: Laboratorios Leon Farma, S.A.

The drug is used for the short-term treatment of moderate pain (especially post-surgery) and for the rapid reduction of high body temperature.

Dosage form: solution for infusion

ATC code: N02BE01

Manufacturer: Axa Parenterals Ltd.

The drug is used to treat various infections in adults and children (including newborns), such as pneumonia, exacerbation of chronic bronchitis, complicated urinary tract infections (including pyelonephritis), soft tissue infections (cellulitis, wound infections), and abdominal cavity infections. It is also used for the prevention of infections following various surgeries.

Dosage form: powder for injection solution

ATC code: J01DC02

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is used to treat many infections in adults and children from 3 months of age, specifically: acute tonsillitis, pharyngitis, bacterial sinusitis, otitis media, exacerbation of chronic bronchitis, cystitis, pyelonephritis, uncomplicated skin and soft tissue infections, as well as early manifestations of Lyme disease.

Dosage form: tablets, film-coated

ATC code: J01DC02

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is used to treat many infections in adults and children from 3 months of age, specifically: acute tonsillitis, pharyngitis, bacterial sinusitis, otitis media, exacerbation of chronic bronchitis, cystitis, pyelonephritis, uncomplicated skin and soft tissue infections, as well as early manifestations of Lyme disease.

Dosage form: tablets, film-coated

ATC code: J01DC02

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is used to treat many infections in adults and children from 3 months of age, specifically acute tonsillitis, pharyngitis, sinusitis, otitis, exacerbation of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.

Dosage form: tablets, film-coated

ATC code: J01DC02

Manufacturer: Medochemie Limited

The drug is used to treat many infections in adults and children, including community-acquired pneumonia, exacerbation of chronic bronchitis, complicated urinary tract infections (including pyelonephritis), soft tissue infections (cellulitis, erysipelas, wound infections), and intra-abdominal infections. It is also used for the prevention of infections following various surgical procedures.

Dosage form: powder for injection solution

ATC code: J01DC02

Manufacturer: Medochemi Limited (full-cycle manufacturing)

The drug is used to treat many infections in adults and children from 3 months of age, specifically acute tonsillitis, pharyngitis, sinusitis, otitis, exacerbation of chronic bronchitis, cystitis, pyelonephritis, skin infections, and early manifestations of Lyme disease.

Dosage form: tablets, film-coated

ATC code: J01DC02

Manufacturer: Medochemie Limited

The drug is used to treat pneumonia, exacerbation of chronic bronchitis, complicated urinary tract infections (including pyelonephritis), soft tissue infections (cellulitis, erysipelas, wound infections), intra-abdominal infections, as well as for the prevention of infections following various surgical operations.

Dosage form: powder for injection solution

ATC code: J01DC02

Manufacturer: Medochemi Limited (full-cycle manufacturing)

The drug is intended for the treatment of advanced renal cell carcinoma in cases where a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC code: L01XE17

Manufacturer: Shilpa Medica Limited

The drug is prescribed for the treatment of advanced renal cell carcinoma if a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC code: L01XE17

Manufacturer: Shilpa Medica Limited

The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EK01

Manufacturer: Synthon Hispania, S.L.

The drug is intended for the treatment of advanced renal cell carcinoma (kidney cancer) in cases where a previous course of systemic therapy has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EK01

Manufacturer: Synthon Hispania, S.L.

The drug is used in the event of a stroke (in the acute phase, as well as for treating the consequences), in cases of traumatic brain injury and its neurological manifestations, as well as for cognitive impairment and behavioral changes due to chronic vascular or degenerative brain disorders.

Dosage form: solution, oral

ATC code: N06BX06

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is used in the case of stroke (in the acute phase and for the consequences of cerebral circulation disorders), traumatic brain injuries, as well as for cognitive impairment and behavioral changes caused by chronic vascular or degenerative brain disorders.

Dosage form: solution for injection

ATC code: N06BX06

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is used in the case of stroke (in the acute phase and for the consequences of cerebral circulation disorders), traumatic brain injuries, as well as for cognitive impairment and behavioral changes caused by chronic vascular or degenerative brain disorders.

Dosage form: solution for injection

ATC code: N06BX06

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is used in the case of stroke (in the acute phase and for the treatment of its consequences), in cases of traumatic brain injury, as well as for cognitive and behavioral disorders caused by chronic vascular or degenerative brain disorders.

Dosage form: tablets, film-coated

ATC code: N06BX06

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is indicated for the treatment of patients with type 2 diabetes mellitus (as an adjunct to diet and exercise) in cases where glucose levels are not controlled by metformin alone, or when switching from separate preparations of vildagliptin and metformin.

Dosage form: tablets, film-coated

ATC code: A10BD08

Manufacturer: JSC "Farmak" (primary and secondary packaging, labeling, batch release of bulk products manufactured by Oman Pharmaceuticals Products Co. LLC, Oman)

The drug is intended for the treatment of adult patients with type 2 diabetes mellitus as an adjunct to diet and physical exercise. It is used when glucose levels are not controlled by metformin alone, or when the patient is already taking a combination of vildagliptin and metformin separately.

Dosage form: tablets, film-coated

ATC code: A10BD08

Manufacturer: JSC "Farmak" (primary and secondary packaging, labeling, batch release from bulk products of the manufacturer Oman Pharmaceuticals Products Co. LLC, Oman)

The drug is used for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.

Dosage form: solution for injection

ATC code: A10AE04

Manufacturer: Farmak JSC

The drug is used to treat arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years. It is also prescribed for adults with heart failure.

Dosage form: tablets

ATC code: C09CA06

Manufacturer: Sanovel Ilac Sanai ve Ticaret A.S.

The drug is prescribed to adult patients who are not candidates for stem cell transplantation for the treatment of myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Dosage form: powder for injection suspension

ATC code: L01BC07

Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging)

The drug is intended for the treatment of adult patients who are not candidates for stem cell transplantation, for the following diseases: intermediate and high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) with a certain blast content in the bone marrow, as well as acute myeloid leukemia (AML).

Dosage form: powder for injection suspension

ATC code: L01BC07

Manufacturer: Intas Pharmaceuticals Limited (manufacturing of medicinal product, primary and secondary packaging)

The drug is intended for the treatment of adult patients with certain subtypes of myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML).

Dosage form: powder for injection solution

ATC code: L01BC07

Manufacturer: MSN Laboratories Private Limited

The drug is intended for the treatment of adult patients who are not candidates for stem cell transplantation, for the following diseases: intermediate-2 and high-risk myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Dosage form: lyophilisate for solution for injection

ATC code: L01BC07

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

The drug is intended for adult patients who are ineligible for stem cell transplantation and suffer from intermediate-2 and high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) with 10–29% blasts in the bone marrow, as well as acute myeloid leukemia (AML) with varying blast levels (20–30% or over 30% depending on the classification).

Dosage form: lyophilisate for solution for injection

ATC code: L01BC07

Manufacturer: Nang Quang Pharmaceutical Co. Ltd.

The drug is used for the treatment of idiopathic Parkinsonism as monotherapy, as well as an adjunct therapy when used with dopamine agonists or levodopa (particularly when end-of-dose levodopa fluctuations are observed).

Dosage form: tablets

ATC code: N04BD02

Manufacturer: Dzhenefarm SA (manufacturing, primary and secondary packaging, quality control and batch release)

The drug is prescribed for the treatment of treatment-resistant schizophrenia, to reduce the risk of suicidal behavior in schizophrenia or schizoaffective disorders, and for the treatment of psychotic disorders occurring during Parkinson's disease.

Dosage form: tablets

ATC code: N05AH02

Manufacturer: PJSC "Tekhnolog"

The drug is prescribed for the treatment of schizophrenia resistant to other medications, to reduce the risk of suicidal behavior in schizophrenia or schizoaffective disorders, and for the treatment of psychotic disorders occurring during Parkinson's disease.

Dosage form: tablets

ATC code: N05AH02

Manufacturer: PJSC "Tekhnolog"

The drug is intended for the symptomatic treatment of dizziness of various origins in adults.

Dosage form: tablets

ATC code: N07CA52

Manufacturer: Medochemie Limited (full cycle manufacturing; manufacturing of unpackaged product, quality control, batch release)

The drug is intended for the treatment of adult patients with intermediate-2 and high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) in certain clinical cases where stem cell transplantation is not possible.

Dosage form: lyophilisate for solution for injection

ATC code: L01BC07

Manufacturer: Panacea Biotek Pharma Ltd.

The drug is prescribed for the treatment of schizophrenia resistant to other medications, to reduce the risk of suicidal behavior in schizophrenia or schizoaffective disorder, and for the treatment of psychotic disorders occurring during Parkinson's disease.

Dosage form: tablets

ATC code: N05AH02

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is prescribed for the treatment of schizophrenia resistant to other medications, to reduce the risk of repeated suicide attempts in patients with schizophrenia or schizoaffective disorder, and for the treatment of psychotic disorders occurring during Parkinson's disease.

Dosage form: tablets

ATC code: N05AH02

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is used to reduce elevated intraocular pressure in adults with open-angle glaucoma or ocular hypertension if other treatment methods have not provided sufficient results.

Dosage form: drops, ophthalmic

ATC code: S01ED51

Manufacturer: Novartis Manufacturing NV

The drug is used to treat infections caused by susceptible bacteria, including upper and lower respiratory tract infections (pharyngitis, tonsillitis, sinusitis, otitis, bronchitis, pneumonia), skin and soft tissue infections (erysipelas, impetigo, Lyme disease), as well as genital infections.

Dosage form: tablets, film-coated

ATC code: J01FA10

Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.

The drug is intended for the treatment of influenza, as well as for its prevention (after contact with an infected person or during a seasonal epidemic) in adults and children aged 6 years and older with a body weight of over 40 kg.

Dosage form: tablets

ATC code: J05AH02

Manufacturer: Biofarma Ltd (full production cycle, quality control and batch release)

The drug is used to treat infections that require initial infusion therapy, specifically community-acquired pneumonia and inflammatory diseases of the pelvic organs (e.g., endometritis or salpingitis).

Dosage form: powder for solution for infusion

ATC code: J01FA10

Manufacturer: Immacul Lifesciences Private Limited